Thomson Reuters, a pharmaceutical company that is almost forgotten by the people of Hong Kong Island, stands quietly in the old industrial area of Kowloon, Hong Kong Island.
This company was founded by Yu Donglai, a descendant of a mainland medical family, after he came to Hong Kong Island at the beginning of this century. With the concept of "benevolence to all living beings", it promoted many traditional Chinese medicine prescriptions from the mainland in Hong Kong Island. It once prepared Angong Niuhuang Pills and Baifeng Pills, which are well-known in Southeast Asia.
The Yu family's patriotism is also deeply ingrained. During the Anti-Japanese War, they risked using Hong Kong Island as their base to maintain the supply of medicinal materials from the mainland. Especially after the war, they devoted themselves to supporting the University of Hong Kong and medical education in the country.
Over the past few decades, the two words "Kang Sheng" have been a heavy golden signboard in the Chinese medicine industry in Hong Kong Island.
However, under the ruthless impact of the times, Hong Kong Island in the 1970s was flooded with Western medicine, which had a huge impact on traditional Chinese medicine.
In addition, the younger generation almost kept their distance from their ancestors' medicine jars, and the glory of Kangsheng Pharmaceutical began to gradually fade.
Even more fatal was the decline of traditional Chinese medicine, the instability of its efficacy, and the market's lack of recognition of its importance. Yu Donglai saw that Kangsheng Pharmaceutical was increasingly exhausted, and in order to survive, he had to make a painful decision and began to transform into Western medicine.
However, this road is fraught with obstacles. The funds accumulated by our ancestors poured into Western medicine research laboratories and generic drug production.
The investment is huge, but the output is like a miser's treasury, squeezing out only a few cold and trauma medicines, the effects are mediocre or even worse than the originals, and the cost remains high.
Kangsheng Pharmaceutical, whose market value once reached as high as HK$50 million, saw its share price plummet like a crashed plane due to these unfavorable news, becoming a famous "junk stock" in the Hong Kong stock market, with its market value shrinking to less than HK$10 million.
Even Yu Tung-lai's eldest son, Yu Xing-chung, who, after graduating from the University of Hong Kong and indulging in the volatile capital markets, completely lost confidence in his own company. When Lin Huo-wang, acting like a savior, began aggressively acquiring Kangsheng shares, briefly boosting the stock price to nearly 20 million, Yu Xing-chung unhesitatingly sold his 20% stake.
This undoubtedly cleared the way for Lin Huowang's acquisition plan. He swept up nearly all the scattered chips in the market. Ultimately, aside from founder Yu Donglai, who still held onto a 25% stake symbolizing his final dignity and unwillingness, Xiaolin Tianwang, the young tycoon who had already stirred up the Hong Kong scene before his twenties, spent over ten million to acquire a full 60% stake in Kangsheng Pharmaceutical, becoming the largest shareholder with absolute control.
Then, Lin Huowang's next choice surprised many people.
Although he took away the position of chairman of the board of directors and secured the actual controlling position as the largest shareholder.
However, Lin Huowang still left the position of general manager, who is in charge of the company's daily operations, to the original founding shareholder Yu Donglai.
Therefore, after the change of controlling rights of Kangsheng Pharmaceutical, there was no major change on the surface, and it was still controlled by the old leader.
In this arrangement, Lin Huowang has his own plans.
First, although Kangsheng Pharmaceutical looks very down and out now, its early investment in Western medicine research and development is not completely in vain. It has a ready-made and fairly well-equipped medical laboratory, as well as several PhDs in biomedical science from the University of Hong Kong, all of whom are real scientific research talents. This is exactly the tool that Lin Huowang urgently needs at this moment.
Secondly, he valued Yu Donglai's innate medical philosophy and patriotic qualities inherited from his traditional Chinese medicine family. These made him feel at ease to hand over the company to him for daily management and care.
Third, when Kangsheng Pharmaceutical was in trouble, Lin Huowang's acquisition price was a timely help, which was a sign of respect and trust for this patriotic industrialist, and also a very cost-effective "investment".
However, the return on this investment could never be achieved by the original Kangsheng Pharmaceutical alone, and Lin Huowang's in-depth personal involvement was required.
So...
In the Kangsheng Pharmaceutical laboratory, the white light shone on the sterile operating table. The air was filled with the mixed smell of disinfectant and various chemical reagents, which was quite pungent.
Lin Huowang was wearing a white laboratory coat at this time. His handsome face inevitably showed a little fatigue, but his eyes were staring intently at some molecular structure models listed on the table.
Around him were several core members of Kangsheng Pharmaceutical's Western medicine research and development team, led by Zhao Shengji.
Zhao Shengji, a PhD in biomedicine from the University of Hong Kong, was once a rising star hired by Kangsheng Pharmaceutical, who had devoted all their resources and connections to recruit him. He was about forty years old, wearing thick-bottomed glasses and with messy hair. At this moment, his brow was furrowed, and like Lin Huowang, he stared at the molecular structure models, thinking about something.
The atmosphere in the lab was quite oppressive. The several researchers gathered nearby all had impressive academic backgrounds, some holding PhDs from the University of Hong Kong, others senior researchers. Their faces were filled with expressions of disbelief and skepticism.
"Mr. Xiaolin! It's not that we don't want to try... but the working principle of this male enhancement drug you described is really a bit... too idealistic." A young researcher said helplessly.
"Yes, Mr. Xiaolin. There are quite a few aphrodisiacs in traditional Chinese medicine. But those that are effective, like real wild ginseng, deer antlers, and tiger bone powder, all fetch exorbitant prices. And the effects aren't as immediate as you describe.
As for those cheap things like leek seeds, oysters, and goji berries, no matter how much you eat, they can only be considered food supplements at best, and the effect can be said to be minimal. When traditional Chinese medicine texts mention "yang-strengthening," they mostly refer to warming and nourishing the kidneys, and a gradual approach is recommended. The key is...
My dear, there is more to this chapter. Please click on the next page to continue reading. It will be even more exciting later!
Continue read on readnovelmtl.com
